Diamyd Medical CEO proposed as new Chairman for Cellaviva

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Diamyd Medical CEO proposed as new Chairman for Cellaviva AB

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that its CEO, Anders Essen-Möller is proposed as new Chairman of the Board of Cellaviva AB at Cellaviva’s Annual General Meeting, February 18, 2016. Diamyd Medical is the largest shareholder of Cellaviva AB, Sweden’s first biobank for family saving and research on stem cells from the umbilical cord. “The umbilical cord contains stem cells that can be differentiated into several of the various cells of the body. This technology is one of today’s fastest growing medical research areas and Diamyd Medical’s commitment is primarily due to its interest in regenerative medicine, particularly within the field of type 1 diabetes,” says Anders Essen-Möller, President and CEO of Diamyd Medical. ”Many other, and perhaps sooner applications may become available and transplantation of autologous stem cells may then be a treatment alternative in several situations. It is with excitement that I look forward to get the possibility to influence on this development and in particular to what I can do for Cellaviva’s research-bank that is now being established and to which it will be possible to donate stem cells from the umbilical cord.” The reference below from 2015 gives an overview of the development of stem cells from so called Wharton's jelly, present in the umbilical cord. Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance. (http://www.ncbi.nlm.nih.gov/pubmed/25861624) Kalaszczynska I, Ferdyn K. Biomed Res Int. 2015 http://www.ncbi.nlm.nih.gov/pubmed/25861624 About Cellaviva AB Cellaviva is Sweden’s first biobank for family saving of and research on stem cells from the umbilical cord. Stem cells from the umbilical cord are collected at birth, analyzed, frozen, and saved for possible future use. Every cell in the body is stemming from stem cells that have unique properties, which make them attractive from a medical perspective. The operations work under approval from the Swedish Health and Social Care Inspectorate (IVO). Read more at www.cellaviva.se. About Diamyd Medical Diamyd Medical is dedicated to finding a cure for autoimmune diabetes through pharmaceutical development and investments in stem cell and medical technology. Diamyd Medical develops the diabetes vaccine Diamyd®, an Antigen Based Therapy (ABT) based on the exclusively licensed GAD-molecule. The Company’s licensed technologies for GABA and Gliadin have also potential to become key pieces of the puzzle of a future solution to prevent, treat or cure autoimmune diabetes, and also certain inflammatory diseases. At this time six clinical studies are ongoing with Diamyd®. Diamyd Medical is with its holdings of 39% one of the major shareholders in the stem cell company Cellaviva AB. Stem cells can be expected to be used in Personalized Regenerative Medicine (PRM), for example for restoration of beta cell mass in diabetes patients where the autoimmune component of the disease has been arrested. Diamyd Medical also has holdings in the medtech company Companion Medical, Inc., San Diego, USA and in the gene therapy company Periphagen, Inc., Pittsburgh, USA. Diamyd Medical’s B-share is traded on Nasdaq Stockholm First North under the ticker DMYD B. Remium Nordic AB is the Company’s Certified Adviser. For further information, please contact: Anders Essen-Möller, President and CEO, Diamyd Medical AB Phone: +46 70 55 10 679. E-mail: anders.essen-moller@diamyd.com Mathias Svahn, CEO Cellaviva AB Phone: +46 702 61 55 04. E-mail: mathias.svahn@cellaviva.se Diamyd Medical AB (publ) Kungsgatan 29, SE-111 56 Stockholm, Sweden. Phone: +46 8 661 00 26, Fax: +46 8 661 63 68 E-mail: info@diamyd.com. Reg. no.: 556242-3797. Website: www.diamyd.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 55

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 44

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 42

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 46

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 37

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 55

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 42

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading

Top 5 Most Recently Viewed Articles

Kiavi Launches Major $300 Million Securitization Milestone

Updated Category News Views 292

Kiavi's Significant Securitization Achievement Kiavi, a prominent tech-enabled lender catering to residential real estate investors, has recently made headlines by closing a prominent $300 million rated securitization of residential transition loans (RTLs). This transaction marks Kiavi's 21st under its LHOME shelf, pushing the total to an impressive $5.8 billion in...

Continue Reading
The AI Landscape at CES 2025: Nvidia vs AMD in Focus

Updated Category News Views 285

Current State of the Semiconductor Industry The semiconductor industry is witnessing an exciting showdown between two titans: Nvidia Corp (NASDAQ: NVDA) and Advanced Micro Devices, Inc. (NASDAQ: AMD). Both companies are pivotal players in the race to dominate AI technology, and their journeys are marked by stark contrasts. While Nvidia has been enjoying a remarkable...

Continue Reading
First National Bank Alaska Announces December Dividend Details

Updated Category News Views 104

Overview of Dividend Declarations First National Bank Alaska has recently made an important announcement regarding its dividend payments for the fourth quarter. Following a meeting of the Board of Directors, the bank declared both a regular and a special cash dividend, ensuring shareholders are rewarded for their investment. Regular Cash Dividend Details The regular cash...

Continue Reading
Gilmore Bell Expands Team with New Shareholders in Missouri

Updated Category News Views 161

Gilmore Bell Welcomes New Shareholders Gilmore & Bell, P.C., a prominent public finance law firm, is excited to share recent developments in its Kansas City office. The firm proudly announces the appointment of Laura Connor and Megan Miller as new shareholders, reflecting their commitment to excellence in legal services. About Laura Connor Laura Connor brings a wealth of...

Continue Reading
Westamerica Bancorporation Boosts Shareholder Value with Dividend

Updated Category News Views 108

Westamerica Bancorporation Announces Quarterly Cash Dividend The Board of Directors at Westamerica Bancorporation (NASDAQ: WABC) has made a significant decision to declare a quarterly cash dividend aimed at rewarding its valued shareholders. This dividend is set at $0.44 per share for all common stock outstanding, emphasizing the company's dedication to maintaining...

Continue Reading